Paul Campanelli Insider Trading Transactions
Get free email notifications about insider trading for Paul Campanelli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Campanelli. Paul Campanelli is Chief Executive Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Chief Operating Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Par Pharmaceutical in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP; President - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres-Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Endo International plc ($ENDP) and Group President, Generics in Endo International plc ($ENDP) and President & CEO in Endo International plc ($ENDP) and President, CEO in Endo International plc ($ENDP) and President, Par Pharmaceutical in Endo International plc ($ENDP).
Latest Insider Trading Transactions of Paul Campanelli
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2021 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 7.37 | 188,384 | 1,388,390 | 1,607,550 | 1.8 M to 1.6 M (-10.49 %) |
Apr 06 2021 | ENDP | Endo International ... | Campanelli Paul | Director | Buy | M | 0.00 | 368,300 | 0 | 1,795,934 | 1.4 M to 1.8 M (+25.80 %) |
Apr 06 2021 | ENDP | Endo International ... | Campanelli Paul | Director | Sell | M | 0.00 | 300,000 | 0 | 1,523,403 | 1.8 M to 1.5 M (-16.45 %) |
Apr 06 2021 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 7.37 | 146,400 | 1,078,968 | 1,427,634 | 1.6 M to 1.4 M (-9.30 %) |
Mar 31 2021 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 7.31 | 72,926 | 533,301 | 1,274,034 | 1.3 M to 1.3 M (-5.41 %) |
Aug 12 2020 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 3.40 | 47,250 | 160,650 | 1,197,521 | 1.2 M to 1.2 M (-3.80 %) |
Aug 12 2020 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 3.40 | 69,539 | 236,433 | 1,147,946 | 1.2 M to 1.1 M (-5.71 %) |
Apr 06 2020 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 3.16 | 146,400 | 462,624 | 1,074,985 | 1.2 M to 1.1 M (-11.99 %) |
Mar 31 2020 | ENDP | Endo International ... | Campanelli Paul | Director | Payment of Exercise | F | 3.52 | 72,926 | 256,700 | 921,385 | 994.3 K to 921.4 K (-7.33 %) |
Feb 25 2020 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 6.19 | 92,976 | 575,521 | 844,871 | 937.8 K to 844.9 K (-9.91 %) |
Feb 25 2020 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Buy | M | 0.00 | 208,430 | 0 | 937,847 | 729.4 K to 937.8 K (+28.57 %) |
Feb 25 2020 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Sell | M | 0.00 | 227,445 | 0 | 845,143 | 1.1 M to 845.1 K (-21.21 %) |
Feb 25 2020 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 6.19 | 998 | 6,178 | 729,417 | 730.4 K to 729.4 K (-0.14 %) |
Feb 25 2020 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 6.19 | 24,184 | 149,699 | 727,460 | 751.6 K to 727.5 K (-3.22 %) |
Oct 01 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 3.12 | 1,874 | 5,847 | 675,829 | 677.7 K to 675.8 K (-0.28 %) |
Aug 13 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 2.49 | 47,251 | 117,655 | 673,862 | 721.1 K to 673.9 K (-6.55 %) |
Aug 13 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 2.49 | 69,539 | 173,152 | 624,287 | 693.8 K to 624.3 K (-10.02 %) |
Apr 04 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 8.10 | 146,400 | 1,185,840 | 551,326 | 697.7 K to 551.3 K (-20.98 %) |
Apr 02 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 448,318 | 0 | 2,006,405 | 1.6 M to 2 M (+28.77 %) |
Feb 26 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 10.51 | 998 | 10,489 | 397,726 | 398.7 K to 397.7 K (-0.25 %) |
Feb 25 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 10.38 | 24,184 | 251,030 | 395,769 | 420 K to 395.8 K (-5.76 %) |
Feb 25 2019 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 10.38 | 24,184 | 251,030 | 395,769 | 420 K to 395.8 K (-5.76 %) |
Oct 02 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 16.71 | 1,801 | 30,095 | 344,138 | 345.9 K to 344.1 K (-0.52 %) |
Aug 14 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 15.82 | 70,180 | 1,110,248 | 342,097 | 412.3 K to 342.1 K (-17.02 %) |
Aug 02 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 290,476 | 0 | 1,783,199 | 1.5 M to 1.8 M (+19.46 %) |
Aug 02 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 290,476 | 0 | 1,783,199 | 1.5 M to 1.8 M (+19.46 %) |
Apr 04 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 900,000 | 0 | 1,492,723 | 592.7 K to 1.5 M (+151.84 %) |
Feb 27 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 6.78 | 942 | 6,387 | 269,777 | 270.7 K to 269.8 K (-0.35 %) |
Feb 22 2018 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 6.72 | 24,184 | 162,516 | 267,763 | 291.9 K to 267.8 K (-8.28 %) |
Oct 02 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 8.38 | 1,330 | 11,145 | 216,132 | 217.5 K to 216.1 K (-0.61 %) |
Aug 15 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Buy | P | 7.71 | 6,500 | 50,115 | 213,620 | 207.1 K to 213.6 K (+3.14 %) |
Aug 11 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Option Exercise | A | 7.55 | 971,590 | 7,335,505 | 971,590 | |
Aug 11 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 427,500 | 0 | 675,336 | 247.8 K to 675.3 K (+172.49 %) |
Mar 16 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Buy | P | 10.72 | 2,300 | 24,656 | 207,120 | 204.8 K to 207.1 K (+1.12 %) |
Feb 27 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Payment of Exercise | F | 13.22 | 1,066 | 14,093 | 204,820 | 205.9 K to 204.8 K (-0.52 %) |
Feb 23 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Option Exercise | A | 13.19 | 510,204 | 6,729,591 | 510,204 | |
Feb 23 2017 | ENDP | Endo International ... | Campanelli Paul | President, CEO | Grant | A | 0.00 | 227,445 | 0 | 250,792 | 23.3 K to 250.8 K (+974.19 %) |
Sep 28 2016 | ENDP | Endo International ... | Campanelli Paul | President & CEO | Option Exercise | A | 21.99 | 429,645 | 9,447,894 | 429,645 | |
Sep 28 2016 | ENDP | Endo International ... | Campanelli Paul | President & CEO | Payment of Exercise | F | 22.26 | 1,981 | 44,097 | 202,930 | 204.9 K to 202.9 K (-0.97 %) |
May 11 2016 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Buy | P | 15.53 | 13,000 | 201,890 | 201,069 | 188.1 K to 201.1 K (+6.91 %) |
Feb 25 2016 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Option Exercise | A | 50.22 | 39,875 | 2,002,523 | 39,875 | |
Feb 25 2016 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Grant | A | 0.00 | 11,822 | 0 | 27,189 | 15.4 K to 27.2 K (+76.93 %) |
Feb 25 2016 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Grant | A | 0.00 | 23,645 | 0 | 129,111 | 105.5 K to 129.1 K (+22.42 %) |
Nov 12 2015 | ENDP | Endo International ... | Campanelli Paul | President, Par Phar ... | Grant | A | 0.00 | 2,100 | 0 | 105,466 | 103.4 K to 105.5 K (+2.03 %) |
Nov 12 2015 | ENDP | Endo International ... | Campanelli Paul | President, Par Phar ... | Buy | P | 56.38 | 200 | 11,276 | 188,069 | 187.9 K to 188.1 K (+0.11 %) |
Nov 12 2015 | ENDP | Endo International ... | Campanelli Paul | President, Par Phar ... | Buy | P | 55.62 | 1,900 | 105,678 | 187,869 | 186 K to 187.9 K (+1.02 %) |
Nov 05 2015 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Grant | A | 0.00 | 72,632 | 0 | 103,366 | 30.7 K to 103.4 K (+236.32 %) |
Sep 30 2015 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Option Exercise | A | 61.82 | 56,920 | 3,518,794 | 56,920 | |
Sep 30 2015 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Grant | A | 0.00 | 30,734 | 0 | 30,734 | 0 to 30.7 K |
Sep 30 2015 | ENDP | Endo International ... | Campanelli Paul | Group President, Ge ... | Grant | A | 0.00 | 15,367 | 0 | 15,367 | 0 to 15.4 K |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 32.76 | 50,875 | 1,666,665 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 36.54 | 17,789 | 650,010 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 27.71 | 17,593 | 487,502 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 13.06 | 27,000 | 352,620 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 13.06 | 22,771 | 297,389 | 27,000 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 10.99 | 34,290 | 376,847 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 24.27 | 3,175 | 77,057 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 33.62 | 4,497 | 151,189 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 42.14 | 8,970 | 377,996 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 0.00 | 25,438 | 0 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Option Exercise | D | 0.00 | 25,438 | 0 | 0 | |
Oct 02 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Executive Off ... | Sell | D | 50.00 | 46,017 | 2,300,850 | 0 | 46 K to 0 (-100.00 %) |
Jan 13 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 35.65 | 1,102 | 39,286 | 46,106 | 47.2 K to 46.1 K (-2.33 %) |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,438 | 0 | 25,438 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 32.76 | 50,875 | 1,666,665 | 50,875 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,438 | 0 | 25,438 | |
Jan 09 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 34.01 | 806 | 27,412 | 47,118 | 47.9 K to 47.1 K (-1.68 %) |
Jan 06 2012 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 32.17 | 1,062 | 34,165 | 47,924 | 49 K to 47.9 K (-2.17 %) |
Nov 22 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Chief Operating Off ... | Payment of Exercise | F | 29.56 | 7,009 | 207,186 | 49,794 | 56.8 K to 49.8 K (-12.34 %) |
Mar 24 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 29.00 | 3,039 | 88,131 | 56,803 | 59.8 K to 56.8 K (-5.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.81 | 100 | 3,081 | 59,842 | 59.9 K to 59.8 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.80 | 300 | 9,240 | 59,942 | 60.2 K to 59.9 K (-0.50 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.79 | 723 | 22,261 | 60,242 | 61 K to 60.2 K (-1.19 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.78 | 434 | 13,359 | 60,965 | 61.4 K to 61 K (-0.71 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 2,335 | 71,848 | 61,399 | 63.7 K to 61.4 K (-3.66 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 5,097 | 156,784 | 63,734 | 68.8 K to 63.7 K (-7.41 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 24,732 | 760,509 | 68,831 | 93.6 K to 68.8 K (-26.43 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 200 | 6,149 | 93,563 | 93.8 K to 93.6 K (-0.21 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.74 | 2,500 | 76,850 | 93,763 | 96.3 K to 93.8 K (-2.60 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.73 | 1,100 | 33,803 | 92,263 | 93.4 K to 92.3 K (-1.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.72 | 300 | 9,216 | 97,363 | 97.7 K to 97.4 K (-0.31 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.71 | 600 | 18,426 | 97,663 | 98.3 K to 97.7 K (-0.61 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.70 | 800 | 24,560 | 98,263 | 99.1 K to 98.3 K (-0.81 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.69 | 700 | 21,483 | 99,063 | 99.8 K to 99.1 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 600 | 18,408 | 99,763 | 100.4 K to 99.8 K (-0.60 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.67 | 100 | 3,067 | 100,363 | 100.5 K to 100.4 K (-0.10 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.66 | 200 | 6,132 | 100 | 300 to 100 (-66.67 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 300 | 9,195 | 100,663 | 101 K to 100.7 K (-0.30 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 300 | 9,194 | 100,963 | 101.3 K to 101 K (-0.30 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.64 | 1,275 | 39,066 | 101,263 | 102.5 K to 101.3 K (-1.24 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.63 | 1,637 | 50,141 | 102,538 | 104.2 K to 102.5 K (-1.57 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.62 | 930 | 28,477 | 104,175 | 105.1 K to 104.2 K (-0.88 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.61 | 400 | 12,244 | 105,105 | 105.5 K to 105.1 K (-0.38 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.60 | 100 | 3,060 | 105,505 | 105.6 K to 105.5 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.60 | 100 | 3,060 | 105,605 | 105.7 K to 105.6 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.59 | 300 | 9,177 | 105,705 | 106 K to 105.7 K (-0.28 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.58 | 100 | 3,058 | 106,005 | 106.1 K to 106 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.58 | 975 | 29,816 | 106,105 | 107.1 K to 106.1 K (-0.91 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.57 | 482 | 14,735 | 107,080 | 107.6 K to 107.1 K (-0.45 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.56 | 500 | 15,280 | 107,562 | 108.1 K to 107.6 K (-0.46 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.54 | 1,000 | 30,540 | 108,062 | 109.1 K to 108.1 K (-0.92 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.53 | 1,100 | 33,583 | 109,062 | 110.2 K to 109.1 K (-1.00 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.52 | 500 | 15,260 | 110,162 | 110.7 K to 110.2 K (-0.45 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.50 | 550 | 16,775 | 110,662 | 111.2 K to 110.7 K (-0.49 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.47 | 100 | 3,047 | 111,212 | 111.3 K to 111.2 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.45 | 100 | 3,045 | 111,312 | 111.4 K to 111.3 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.43 | 200 | 6,086 | 111,412 | 111.6 K to 111.4 K (-0.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.42 | 100 | 3,042 | 111,612 | 111.7 K to 111.6 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.41 | 100 | 3,041 | 111,712 | 111.8 K to 111.7 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.39 | 100 | 3,039 | 111,812 | 111.9 K to 111.8 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.19 | 300 | 9,357 | 111,912 | 112.2 K to 111.9 K (-0.27 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.19 | 400 | 12,474 | 112,212 | 112.6 K to 112.2 K (-0.36 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.18 | 900 | 28,062 | 112,612 | 113.5 K to 112.6 K (-0.79 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.17 | 600 | 18,702 | 113,512 | 114.1 K to 113.5 K (-0.53 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.16 | 100 | 3,116 | 114,112 | 114.2 K to 114.1 K (-0.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.13 | 6 | 187 | 114,212 | 114.2 K to 114.2 K (-0.01 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.06 | 800 | 24,848 | 114,218 | 115 K to 114.2 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.05 | 1,966 | 61,044 | 115,018 | 117 K to 115 K (-1.68 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.05 | 1,350 | 41,911 | 116,984 | 118.3 K to 117 K (-1.14 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.04 | 200 | 6,208 | 118,334 | 118.5 K to 118.3 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.04 | 833 | 25,856 | 118,534 | 119.4 K to 118.5 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.03 | 101 | 3,134 | 119,367 | 119.5 K to 119.4 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.02 | 100 | 3,102 | 119,468 | 119.6 K to 119.5 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 31.01 | 200 | 6,202 | 119,568 | 119.8 K to 119.6 K (-0.17 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.99 | 162 | 5,020 | 119,768 | 119.9 K to 119.8 K (-0.14 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.98 | 100 | 3,098 | 119,930 | 120 K to 119.9 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.96 | 900 | 27,864 | 120,030 | 120.9 K to 120 K (-0.74 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.96 | 1,000 | 30,955 | 120,930 | 121.9 K to 120.9 K (-0.82 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.95 | 700 | 21,665 | 121,930 | 122.6 K to 121.9 K (-0.57 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 13.06 | 24,885 | 324,998 | 49,771 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 28.79 | 7,500 | 215,925 | 0 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 27.71 | 5,864 | 162,491 | 17,593 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 10.99 | 68,591 | 753,815 | 34,290 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | M | 24.27 | 9,525 | 231,172 | 3,175 | |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.95 | 1,200 | 37,134 | 122,630 | 123.8 K to 122.6 K (-0.97 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.90 | 1,200 | 37,080 | 123,830 | 125 K to 123.8 K (-0.96 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.89 | 1,200 | 37,068 | 125,030 | 126.2 K to 125 K (-0.95 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.88 | 1,400 | 43,232 | 126,230 | 127.6 K to 126.2 K (-1.10 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.87 | 200 | 6,174 | 127,630 | 127.8 K to 127.6 K (-0.16 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.86 | 100 | 3,086 | 127,830 | 127.9 K to 127.8 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.85 | 200 | 6,170 | 127,930 | 128.1 K to 127.9 K (-0.16 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.84 | 100 | 3,084 | 128,130 | 128.2 K to 128.1 K (-0.08 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.83 | 300 | 9,249 | 128,230 | 128.5 K to 128.2 K (-0.23 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.82 | 1,500 | 46,230 | 128,530 | 130 K to 128.5 K (-1.15 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.81 | 2,300 | 70,863 | 130,030 | 132.3 K to 130 K (-1.74 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.80 | 1,300 | 40,040 | 132,330 | 133.6 K to 132.3 K (-0.97 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.79 | 500 | 15,395 | 133,630 | 134.1 K to 133.6 K (-0.37 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.78 | 1,300 | 40,014 | 134,130 | 135.4 K to 134.1 K (-0.96 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 2,300 | 70,771 | 135,430 | 137.7 K to 135.4 K (-1.67 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.77 | 3,601 | 110,785 | 137,730 | 141.3 K to 137.7 K (-2.55 %) |